Home - Products - Angiogenesis - EGFR - Methyl 2,5-dihydroxycinnamate

Methyl 2,5-dihydroxycinnamate

CAS No. 63177-57-1

Methyl 2,5-dihydroxycinnamate( —— )

Catalog No. M27654 CAS No. 63177-57-1

Methyl 2,5-dihydroxycinnamate is an EGF receptor-associated tyrosine kinases inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 52 In Stock
5MG 52 In Stock
10MG 92 In Stock
25MG 187 In Stock
50MG 346 In Stock
100MG 517 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Methyl 2,5-dihydroxycinnamate
  • Note
    Research use only, not for human use.
  • Brief Description
    Methyl 2,5-dihydroxycinnamate is an EGF receptor-associated tyrosine kinases inhibitor.
  • Description
    Methyl 2,5-dihydroxycinnamate is an EGF receptor-associated tyrosine kinases inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    Apoptosis|BiP
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    63177-57-1
  • Formula Weight
    194.186
  • Molecular Formula
    C10H10O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (643.73 mM)
  • SMILES
    COC(=O)\C=C\c1cc(O)ccc1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Oida Y, et al. Induction of BiP, an ER-resident protein, prevents the neuronal death induced by transient forebrain ischemia in gerbil. Brain Res. 2008 May 7;1208:217-24.
molnova catalog
related products
  • CO-1686 hydrobromide

    A potent, highly selective, irreversible inhibitor of mutant EGFR with Ki of 21.5 nM for EGFR L858R/T790M.

  • VUF 10166

    VUF10166 is a novel, potent and competitive antagonist for 5-HT3A receptor with Ki of 0.04 nM, its affinity at 5-HT3AB receptor is significantly lower.

  • Poziotinib

    Poziotinib (HM781-36B, NOV120101) is an irreversible pan-HER inhibitor with IC50 of 3.2/5.3 nM/23.5 nM for HER1/HER2/HER4.